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Case report
B.T., a 26 year old pregnant woman who reached 41
weeks of gestation (gravida 1, para 0), came to our ob-
servation in June 1994, for a spontaneous onset of
labour. She was taken care of elsewhere during preg-
nancy. The course of gestation had been normal and no
risk factor was evident from both the clinical history and
the analysis of the patient’s clinical condition. Laborato-
ry tests were normal. Previous ultrasound scans re-
vealed a fetal growth at the lower end of the normal
range expected for gestational age, but Doppler studies
showed that the fetus was healthy. The patient’s body
weight was 64 kg (increased 10 kg during pregnancy)
and blood pressure was 110/70 mmHg. After an un-
eventful labour, a female baby weighing 2600 g, with Ap-
gar scores of 8/9, was delivered vaginally. However, the
infant presented at birth a left dorsolumbar
hemispondylia and an oesophageal atresia type III.
None of these anomalies had been diagnosed prenatal-
ly through a serial sonographic follow-up. The neonatal
karyotype was 46, XX. Subsequently, the presence of
13 ribs and a little paramedian schisis of the posterior
arches of the first sacral vertebrae (spina bifida occulta)
were also observed; moreover, hypoplasia of the corpus
callosum was diagnosed by nuclear magnetic reso-
nance. The infant underwent surgery repeatedly for cor-
rection of the oesophageal atresia and the
hemispondylia. No correction of spina bifida occulta was
considered necessary at that stage, given its entity and
the absence of clinical neurological deficits. Currently
the child is fourteen years old. A mild and transient gas-
tro-oesophageal reflux, besides a 30° kyphosis and 25°
scoliosis of the dorsolumbar tract of the rachis requiring
physiotherapy, persist. Nevertheless, the child does not
show any mental nor neurological deficits.
In 2001, the woman, at 33 years of age, became preg-
nant again; however, fetal death occurred at 20 weeks’
gestation. No fetal malformations were revealed by the
autopsy; however, the placenta showed largely extend-
ed infarctions. Since the woman desired a further preg-
nancy, though other investigations gave normal results,
both parents underwent screening for thrombophilias.
Eterozygosity for both the C677T and the A1298C mu-
tation in the methylene tetrahydrofolate reductase
(MTHFR) gene, as well as for the Factor V Leiden mu-
tation (G1691A) were found in the woman. Eterozygos-
ity for the C677T MTHFR gene mutation was also
demonstrated in the husband.
A screening for thrombophilias was therefore advised to
be carried out in the live infant as well, which brought to
the identification of eterozygosity for the Factor V Leiden
mutation and homozygosity for the C677T MTHFR gene
mutation.
In 2003, the woman, (gravida 3, para 1), came to us
again for obstetric care. Early therapy with low molecu-
lar weight heparin (enoxaparin) was carried out at a
dose of 4000 units/day, in addition to treatment with folic
acid and vitamins B6 and B12. The course of this preg-
nancy was uneventful. Blood coagulation tests, as well
as the levels of Antithrombin III, Protein C, Protein S and
homocysteine kept within normal ranges throughout the
pregnancy. Screening for thrombophilias through amnio-
centesis revealed eterozygosity for the C677T MTHFR
gene mutation. The prenatal ultrasound follow-up
showed normal fetal growth and absence of anomalies.
Doppler studies showed normal velocimetry patterns. A
caesarean section was performed due to fetal face pres-
entation at 39 weeks’ gestation, and a healthy male ba-
by weighing 3050g, with Apgar scores 9/10, was deliv-
ered. 
Discussion
Before 1993, known inherited thrombophilias included
deficiencies of protein C, protein S and antithrombin;
however, taken together, such defects are responsible
for only 15% of familial thrombophilias, and less than
5% of all venous thromboses (1). Thus, the possibility of
finding a relationship between thrombophilia and obstet-
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ric pathologies was remarkably low. More recently, nov-
el genetic thrombophilias have been identified. The re-
sistance to the anticoagulant activity of activated Protein
C (APC), accounting for up to 40% of all thromboses, is
due to Factor V Leiden mutation in 95% of cases (2): the
estimated carrier frequency of this mutation is about 5%
in the Caucasian population (European, Jews, Israeli
Arabs, Indians) (3) reaching to about 10-15% in some
European countries (4). Hyperhomocysteinemia result-
ing from the C677T mutation in the MTHFR gene is
known since the sixties as a risk factor for vascular dam-
age (5), but only recently it has been implicated in ob-
stetric complications (6): homozygosity for this mutation
is reported in about 12% of the white population (7). The
G20210A mutation in the factor II (prothrombin) gene is
another cause of thrombophilia: heterozygosity for such
mutation is reported in 2-3% of the white European pop-
ulation (8).
Thus, recent studies have demonstrated an increasing
role of genetic and acquired thrombophilias in the patho-
genesis of several serious obstetric pathologies, such
as deep venous thrombosis in pregnancy, preeclamp-
sia, spontaneous miscarriage, late fetal loss, abruptio
placentae and other placental lesions (placental infarc-
tions) and intrauterine growth retardation (6, 9, 10). 
Hyperhomocysteinemia has also been associated with
an increased incidence of neural tube defects (NTD),
which is related to impaired function of methionine syn-
thetase, an enzyme involved in myelin synthesis (11). 
Even more recently it has been suggested that throm-
bophilias represent risk factors for those fetal malforma-
tions, whose pathogenesis is potentially related to a vas-
cular thrombotic or ischemic event. The C677T mutation
in the MTHFR gene has been found to be associated
with terminal limb defects (12). It has also been suggest-
ed that Factor V Leiden, increased lipoprotein (a), pro-
tein C and protein S deficiency exert a role in the patho-
genesis of congenital porencephaly (13). Association of
the Leiden mutation with congenital microcephaly has
also been reported (14). A high prevalence of factor V
Leiden and the R353Q factor VII polimorphism has been
found in patients with intestinal atresia (15). Interesting-
ly, the latter study failed to demonstrate thrombophilias
in some patients, suggesting a multifactorial etiology for
such pathology (15).
Only a few studies have investigated the role of fetal
thrombophilia in the pathogenesis of the above men-
tioned obstetric pathologies, although it must be remind-
ed that some thrombophilic mutations are inherited in an
autosomal dominant fashion and, therefore, may be po-
tentially inherited also by the father: i.e., a fetus may car-
ry a thrombophilia, even if the maternal screening is
negative. One study has shown that early spontaneous
miscarriage and placental infarction are significantly as-
sociated with a fetal rather than a maternal thrombophil-
ia: interestingly, infarctions were detected in the distribu-
tion of the fetal vessels coursing along the fetal side of
the placenta (16). We may reasonably speculate that
many more obstetric pathologies may be related to fetal
thrombophilias. Similarly, some fetal malformations
might be correlated to a fetal rather than a maternal
thrombophilia. Relevant to this, an investigation has
demonstrated a significant association between the fe-
tal, but not the parental, C677T mutation in the MTHFR
gene with the risk of NTD (17). 
In our case, the first daughter of the couple carried a
double thrombophilia, one of which was due to the ho-
mozygosity for the C677T MTHFR gene mutation: the
thrombogenic and teratogenic (regarding NTD) risk was
therefore higher than expected on the basis of just the
maternal genotype. She suffered from hemispondylia
and spina bifida occulta, as described above.
Oesophageal atresia was also observed in this patient.
In the study by Johnson and Meyers investigating the
prevalence of fetal thrombophilias in cases of intestinal
atresia (2001) (15), oesophageal atresia was not includ-
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Figure 1 - Hypoplasia of corpus callosum of the first daughter.
Figure 2 - Condition of the spine of the first daughter at 10 years
of age.
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ed amongs the investigated malformations, since its
pathogenesis is postulated to be different from ischemic
insult. Our case does not demonstrate a causal relation-
ship between fetal thrombophilia and oesophaegal atre-
sia, but encourages new investigations to be carried out
in order to evaluate a possible association between the
two factors. 
Moreover, this case report suggests the question of
whether, in the case of a maternal thrombophilia, the fa-
ther should also be screened for thrombophilia, and
whether, if the screening is positive, an early maternal
therapy should be administered. In fact, although there
is no definitive evidence indicating the possibility of im-
proving the outcome of subsequent pregnancies, pre-
liminary studies suggest a favourable effect of low mo-
lecular weight heparin on the pregnancy outcome of
women with thrombophilia and with a history of obstetric
complications (18). Moreover, there are no contraindica-
tions regarding the use of folic acid and vitamins B6 and
B12 before and throughout the pregnancy, whereas their
positive effect has been reported (9). 
In our case, the third pregnancy of the couple, during
which early therapy with enoxaparin, folic acid, vitamins
B6 and B12 was carried out, was uneventful and the in-
fant is currently healthy: however, this infant was only
heterozygous for the C677T MTHFR gene mutation.
Nevertheless, although any firm conclusion on this issue
may not be drawn, this report suggests that the above
described therapy is effective in preventing complica-
tions potentially related to parental and fetal throm-
bophilias.
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